| Trial registration number
|
ChiCTR2200056817 |
Full text link
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
http://www.chictr.org.cn/showproj.aspx?proj=167930
|
First author
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Yingxia Liu
|
Contact
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
yingxialiu@hotmail.com
|
Registration date
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2022-02-18
|
Recruitment status
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Recruiting
|
Study design
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
RCT
|
Allocation
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Randomized
|
Design
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Parallel
|
Masking
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not reported
|
Center
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
unclear
|
Study aim
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Treatment
|
Inclusion criteria
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
1. At least 18 years of age,
2. Within 5 days prior to screening, sarS-COV-2 infection was confirmed by PCR test with or without COVID-19 related symptoms,
3. Male or female (contraceptive or infertile).
|
Exclusion criteria
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
1. Recurrent COVID-19 patients,
2. A history of severe allergic reactions, including systemic urticaria and hypersensitivity to vascular edema,
3. Have been treated with plasma SARS-COV-2 antibody during the convalescence of COVID-19,
4. Have received other investigational drugs for sarS-COV-2,
5. Pregnant women, 6. The study physician determines any inappropriateness for participation in the project.
|
Number of arms
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2
|
Funding
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
The Third People's Hospital of Shenzhen
|
Inclusion age min
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
18
|
Inclusion age max
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
100
|
Countries
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
China
|
Type of patients
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
No restriction on type of patients
|
Severity scale
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
0: No restriction on type of patients
|
Total sample size
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
150
|
primary outcome
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Percentage of negative nucleic acid tests (Nasopharyngeal swabs/respiratory secretions);
|
Notes
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
| Declared number of arm (2.0)
differs from found arms (3.0)
|
Phase
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Phase 0
|
Arms
Last imported at : April 29, 2022, 10 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "", "treatment_id": 2451, "treatment_name": "Sc-3460", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|